"Antibodies, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulins produced in response to VIRAL ANTIGENS.
| Descriptor ID |
D000914
|
| MeSH Number(s) |
D12.776.124.486.485.114.254 D12.776.124.790.651.114.254 D12.776.377.715.548.114.254
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Viral".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Viral".
This graph shows the total number of publications written about "Antibodies, Viral" by people in this website by year, and whether "Antibodies, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 3 | 4 |
| 1997 | 1 | 1 | 2 |
| 1998 | 0 | 1 | 1 |
| 1999 | 3 | 1 | 4 |
| 2000 | 2 | 2 | 4 |
| 2001 | 0 | 4 | 4 |
| 2002 | 3 | 2 | 5 |
| 2003 | 1 | 5 | 6 |
| 2005 | 1 | 4 | 5 |
| 2006 | 0 | 4 | 4 |
| 2007 | 2 | 3 | 5 |
| 2008 | 1 | 6 | 7 |
| 2009 | 3 | 3 | 6 |
| 2010 | 2 | 0 | 2 |
| 2011 | 4 | 8 | 12 |
| 2012 | 4 | 3 | 7 |
| 2013 | 5 | 2 | 7 |
| 2014 | 2 | 4 | 6 |
| 2015 | 6 | 6 | 12 |
| 2016 | 6 | 1 | 7 |
| 2017 | 4 | 1 | 5 |
| 2018 | 4 | 2 | 6 |
| 2019 | 2 | 2 | 4 |
| 2020 | 6 | 11 | 17 |
| 2021 | 16 | 22 | 38 |
| 2022 | 0 | 13 | 13 |
| 2023 | 0 | 11 | 11 |
| 2024 | 6 | 6 | 12 |
| 2025 | 5 | 3 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibodies, Viral" by people in Profiles.
-
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial. J Infect Dis. 2025 Dec 20; 232(6):1319-1329.
-
Genetic markers of enhanced functional antibody responses to COVID-19 vaccination. Vaccine. 2025 Aug 13; 61:127379.
-
Using SARS-CoV-2 red cell kodecytes to assess vaccine-induced immune response to the conserved 1147-58 region of the spike protein in Indian blood donors: exploring the potential role of blood transfusion services in population surveillance. Transfus Clin Biol. 2025 Aug; 32(3):286-291.
-
Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins. Immunity. 2025 Apr 08; 58(4):980-996.e7.
-
Immune history shapes human antibody responses to H5N1 influenza viruses. Nat Med. 2025 May; 31(5):1454-1458.
-
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial. Clin Infect Dis. 2025 02 05; 80(1):223-227.
-
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost. Nat Commun. 2025 Jan 17; 16(1):759.
-
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines. JCI Insight. 2025 Jan 09; 10(4).
-
Mucosal vaccination against SARS-CoV-2 using recombinant influenza viruses delivering self-assembling nanoparticles. Vaccine. 2025 02 06; 46:126668.
-
Measures of Population Immunity Can Predict the Dominant Clade of Influenza A (H3N2) in the 2017-2018 Season and Reveal Age-Associated Differences in Susceptibility and Antibody-Binding Specificity. Influenza Other Respir Viruses. 2024 11; 18(11):e70033.